This comprehensive literature review explores the potential benefits and risks of using psychedelics, such as LSD and psilocybin, as a treatment for cancer patients experiencing... Continue reading
Page 2
This study investigates the efficacy of single-dose psilocybin-assisted therapy for patients with major depressive disorder (MDD) through a double-blind, randomized, placebo-controlled clinical trial. The findings... Continue reading
A recent double-blind, randomized, and placebo-controlled study has demonstrated that psilocybin-assisted therapy can significantly improve the psycho-social-spiritual well-being of cancer patients. The research found that... Continue reading
An international web-based survey examining the risks and benefits of psilocybin use among individuals with bipolar disorder found that while some participants reported potential therapeutic... Continue reading
Psilocybin, a psychedelic compound found in mushrooms, shows promise as a treatment for psychiatric disorders like depression, anxiety, PTSD, OCD, and substance use disorders. The... Continue reading
This systematic review examines the therapeutic potential and safety profile of psilocybin, a naturally occurring psychoactive compound, in treating psychiatric disorders such as treatment-resistant depression,... Continue reading
This paper presents a comprehensive study evaluating the efficacy and safety of psilocybin-assisted therapy in treating major depressive disorder (MDD) over a 12-month follow-up period,... Continue reading
A randomized controlled trial showed that psilocybin treatment rapidly and sustainably reduced anxiety and depression symptoms in patients with life-threatening cancer. Psilocybin led to significant... Continue reading
Showing 11–18 of 18 posts